No Data
No Data
Express News | Ocuphire Pharma Participates In ARVO SIG Panel And ASRS 42nd Annual Scientific Meeting To Highlight APX3330 For Diabetic Retinopathy
Express News | Ocuphire Pharma Announces Upcoming Presentations On Lead Candidate APX3330 For Diabetic Retinopathy At Clinical Trials At The Summit On June 8 And Retinal Imaging Biomarkers & Endpoints Summit June 25-27
Ocuphire Pharma(OCUP.US) Officer Buys US$6,177.5 in Common Stock
Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
Ocuphire Pharma(OCUP.US) Officer Buys US$8,772.5 in Common Stock
Ocuphire Pharma Is Maintained at Buy by Canaccord Genuity
mohammad ahmady : y